Skip to main content
. 2022 Jan 11;9(1):20. doi: 10.3390/jcdd9010020

Table 4.

Associations between LVRR and the primary study endpoint (all-cause death or heart transplantation).

Model 1 Model 2 Model 3
HR 95% CI p Value HR 95% CI p Value HR 95% CI p Value
LVRR 0.35 0.24–0.51 <0.001 0.40 0.27–0.58 <0.001 0.29 0.14–0.62 0.001
Age (years) 1.05 1.03–1.06 <0.001 1.03 0.99–1.07 0.0765
Male sex 1.12 0.78–1.60 0.541 0.65 0.33–1.30 0.656
Hypertension 0.87 0.48–1.59 0.660
Diabetes Mellitus 1.99 1.09–3.64 0.025
eGFR(mL/min) 0.99 0.98–1.01 0.274
Hemoglobin (g/L) 1.11 0.92–1.33 0.277
logNT-proBNP (ng/L) 1.21 0.88–1.67 0.239
logHF duration (months) 1.07 0.89–1.27 0.466
III-IV NYHA class 1.95 1.04–3.65 0.037
Initial iLVEDD (mm) 0.93 0.87–0.99 0.037
Initial LVEF (%) 0.99 0.94–1.05 0.696
Sinus ryhthm 1.06 0.54–2.07 0.875
Absence of LBBB 1.24 0.55–2.89 0.602
QRS complex (ms) 1.00 0.99–1.01 0.959
Aldosterone Antagonist 1.92 0.88–4.16 0.098
Diuretic 0.63 0.18–2.27 0.486
Statin 0.68 0.37–1.25 0.226
Betablocker 0.40 0.16–0.99 0.037

Results presented as HRs and 95% CIs from the Cox Proportional Hazards regression models: Model 1 was unadjusted; Model 2 adjusted for age and sex; Model 3 further adjusted for the variables that were found to be associated with LVRR in the logistic regression analyses Abbreviations: CI = confidence interval; eGFR = estimated glomerular filtration rate; HF = heart failure; HR = hazard ratio; iLVEDD = indexed left ventricular end-diastolic diameter; LBBB = left bundle branch block; LVEF = left ventricle ejection fraction; LVRR = left ventricular reverse remodelling; NTproBNP = N-terminal prohormone of brain natriuretic peptide; NYHA = New York Heart Association.